NICOLAI WAGTMANN

Person

CONCORD, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Treatment regimens using anti-NKG2A antibodies
- Patent number 12,037,392
- Issue date Jul 16, 2024
- Innate Pharma
- Pascale Andre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric Fc-fused proteins
- Patent number 11,787,864
- Issue date Oct 17, 2023
- Dragonfly Therapeutics, Inc.
- Ann F. Cheung
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Siglec-9-neutralizing antibodies
- Patent number 11,623,954
- Issue date Apr 11, 2023
- Innate Pharma
- Stephanie Cornen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neutralization of inhibitory pathways in lymphocytes
- Patent number 11,572,410
- Issue date Feb 7, 2023
- Innate Pharma
- Pascale Andre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy using antibody to human Siglec-9 and antibody t...
- Patent number 11,447,545
- Issue date Sep 20, 2022
- Innate Pharma
- Stéphanie Cornen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancers using anti-NKG2A agents
- Patent number 11,225,519
- Issue date Jan 18, 2022
- Innate Pharma
- Pascale Andre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Siglec-10 antibodies
- Patent number 11,083,785
- Issue date Aug 10, 2021
- Innate Pharma
- Stephanie Cornen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Siglec neutralizing antibodies
- Patent number 11,078,274
- Issue date Aug 3, 2021
- Innate Pharma
- Stephanie Cornen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Neutralization of inhibitory pathways in lymphocytes
- Patent number 10,870,700
- Issue date Dec 22, 2020
- Innate Pharma
- Pascale Andre
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES
- Publication number 20240368281
- Publication date Nov 7, 2024
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16, AND CEACAM5
- Publication number 20240124607
- Publication date Apr 18, 2024
- Merck Sharp & Dohme LLC
- Amy M. Beebe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES
- Publication number 20230303691
- Publication date Sep 28, 2023
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...
- Publication number 20230303702
- Publication date Sep 28, 2023
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Formulation, Dosage Regimen, and Manufacturing Process for Heterodi...
- Publication number 20230272041
- Publication date Aug 31, 2023
- Dragonfly Therapeutics, Inc.
- Mitchell Bigelow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND EGFR
- Publication number 20230257467
- Publication date Aug 17, 2023
- Dragonfly Therapeutics, Inc.
- Ann F. Cheung
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PPHARMACEUTICAL FORMULATIONS AND THERAPEUTIC USES OF MULTI-SPECIFIC...
- Publication number 20230250176
- Publication date Aug 10, 2023
- Dragonfly Therapeutics, Inc.
- Ann F. Cheung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES
- Publication number 20230235060
- Publication date Jul 27, 2023
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...
- Publication number 20230227562
- Publication date Jul 20, 2023
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY USING ANTIBODY TO HUMAN SIGLEC-9 AND ANTIBODY T...
- Publication number 20230085847
- Publication date Mar 23, 2023
- Innate Pharma
- STÉPHANIE CORNEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC FC-FUSED PROTEINS
- Publication number 20230033425
- Publication date Feb 2, 2023
- Dragonfly Therapeutics, Inc.
- Ann F. Cheung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL FORMULATIONS AND DOSAGE REGIMENS FOR MULTI-SPECIFIC...
- Publication number 20220195065
- Publication date Jun 23, 2022
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC FC-FUSED PROTEINS
- Publication number 20220119533
- Publication date Apr 21, 2022
- Dragonfly Therapeutics, Inc.
- Ann F. CHEUNG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTI-SPECIFIC BINDING PROTEINS THAT BIND BCMA, NKG2D AND CD16, AND...
- Publication number 20220089760
- Publication date Mar 24, 2022
- Dragonfly Therapeutics, Inc.
- Mitchell Bigelow
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEIN BINDING NKG2D, CD16 AND A FIBROBLAST ACTIVATION PROTEIN
- Publication number 20210363261
- Publication date Nov 25, 2021
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SIGLEC NEUTRALIZING ANTIBODIES
- Publication number 20210363249
- Publication date Nov 25, 2021
- Innate Pharma
- STEPHANIE CORNEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTI-SPECIFIC BINDING PROTEINS THAT BIND BCMA, NKG2D AND CD16, AND...
- Publication number 20210317223
- Publication date Oct 14, 2021
- Dragonfly Therapeutics, Inc.
- Mitchell Bigelow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16, AND EGFR, CCR4, OR PD-L1
- Publication number 20210261668
- Publication date Aug 26, 2021
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES
- Publication number 20210238285
- Publication date Aug 5, 2021
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND AN ANTIGEN ASSOCIATED WITH TUMORS,...
- Publication number 20210221894
- Publication date Jul 22, 2021
- Dragonfly Therapeutics, Inc.
- Mitchell Bigelow
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTI-SPECIFIC BINDING PROTEINS THAT BIND HER2, NKG2D, AND CD16, AN...
- Publication number 20210198369
- Publication date Jul 1, 2021
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES
- Publication number 20210122821
- Publication date Apr 29, 2021
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...
- Publication number 20210079102
- Publication date Mar 18, 2021
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SIGLEC-9-NEUTRALIZING ANTIBODIES
- Publication number 20200369765
- Publication date Nov 26, 2020
- Innate Pharma
- STEPHANIE CORNEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY USING ANTIBODY TO HUMAN SIGLEC-9 AND ANTIBODY T...
- Publication number 20200369764
- Publication date Nov 26, 2020
- Innate Pharma
- STÉPHANIE CORNEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES
- Publication number 20200332008
- Publication date Oct 22, 2020
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES
- Publication number 20200299383
- Publication date Sep 24, 2020
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN
- Publication number 20200231679
- Publication date Jul 23, 2020
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEINS BINDING NKG2D, CD16, AND EGFR, HLA-E, CCR4, OR PD-L1
- Publication number 20200216544
- Publication date Jul 9, 2020
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCERS USING ANTI-NKG2A AGENTS
- Publication number 20190322744
- Publication date Oct 24, 2019
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

NICOLAI WAGTMANN

Person

Patents Grantslast 30 patents

Treatment regimens using anti-NKG2A antibodies

Heterodimeric Fc-fused proteins

Siglec-9-neutralizing antibodies

Neutralization of inhibitory pathways in lymphocytes

Combination therapy using antibody to human Siglec-9 and antibody t...

Treatment of cancers using anti-NKG2A agents

Siglec-10 antibodies

Siglec neutralizing antibodies

Neutralization of inhibitory pathways in lymphocytes

Patents Applicationslast 30 patents

TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES

PROTEINS BINDING NKG2D, CD16, AND CEACAM5

NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES

COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...

Formulation, Dosage Regimen, and Manufacturing Process for Heterodi...

PROTEINS BINDING NKG2D, CD16 AND EGFR

PPHARMACEUTICAL FORMULATIONS AND THERAPEUTIC USES OF MULTI-SPECIFIC...

NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES

COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...

COMBINATION THERAPY USING ANTIBODY TO HUMAN SIGLEC-9 AND ANTIBODY T...

HETERODIMERIC FC-FUSED PROTEINS

PHARMACEUTICAL FORMULATIONS AND DOSAGE REGIMENS FOR MULTI-SPECIFIC...

HETERODIMERIC FC-FUSED PROTEINS

MULTI-SPECIFIC BINDING PROTEINS THAT BIND BCMA, NKG2D AND CD16, AND...

PROTEIN BINDING NKG2D, CD16 AND A FIBROBLAST ACTIVATION PROTEIN

SIGLEC NEUTRALIZING ANTIBODIES

MULTI-SPECIFIC BINDING PROTEINS THAT BIND BCMA, NKG2D AND CD16, AND...

PROTEINS BINDING NKG2D, CD16, AND EGFR, CCR4, OR PD-L1

TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES

PROTEINS BINDING NKG2D, CD16 AND AN ANTIGEN ASSOCIATED WITH TUMORS,...

MULTI-SPECIFIC BINDING PROTEINS THAT BIND HER2, NKG2D, AND CD16, AN...

NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES

COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...

SIGLEC-9-NEUTRALIZING ANTIBODIES

COMBINATION THERAPY USING ANTIBODY TO HUMAN SIGLEC-9 AND ANTIBODY T...

NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES

TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES

PROTEINS BINDING NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN

PROTEINS BINDING NKG2D, CD16, AND EGFR, HLA-E, CCR4, OR PD-L1

TREATMENT OF CANCERS USING ANTI-NKG2A AGENTS